HomeSNDX • NASDAQ
add
Syndax Pharmaceuticals Inc
Previous close
$20.57
Day range
$20.48 - $21.24
Year range
$11.22 - $25.34
Market cap
1.79B USD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 77.90M | 85.34% |
Net income | -72.47M | -84.91% |
Net profit margin | — | — |
Earnings per share | -1.00 | -61.29% |
EBITDA | -77.90M | -85.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 577.58M | 19.24% |
Total assets | 612.88M | 23.26% |
Total liabilities | 58.68M | 97.01% |
Total equity | 554.20M | — |
Shares outstanding | 84.97M | — |
Price to book | 3.15 | — |
Return on assets | -38.49% | — |
Return on capital | -42.48% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -72.47M | -84.91% |
Cash from operations | -41.35M | -80.61% |
Cash from investing | -16.29M | 88.16% |
Cash from financing | 258.48M | 58.09% |
Net change in cash | 200.84M | 6,641.99% |
Free cash flow | -17.66M | -44.49% |
About
Founded
2005
Headquarters
Website
Employees
112